glp-1 prescriptions growth q1 2025 Market Size, Scope, Forecast Report 2026 to 2035 Eli Lilly Q1 2025 slides:

Virtual Consultations : Experience the convenience of discussing your weight loss goals, medical history, and current medications in a telehealth appointment, allowing you to benefit from expert care without leaving your home in Florida

While most are approved for the management of type 2 diabetes, some formulations, such as semaglutide (Wegovy) and tirzepatide (Zepbound), have also been approved for chronic weight management in adults with obesity or overweight

However, heterogeneity in outcome definitions and reporting complicates interpretation

Semaglutide targets the GLP-1 pathway, while tirzepatide works on two pathways (GLP-1 and GIP)

Shor, R

Our clinicians provide personalized monitoring to ensure your treatment is both effective and safe